Leaderboards/Renal Diseases and Glomerulopathies

Renal Diseases and Glomerulopathies

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Fádi Fakhouri
University Hospital of Lausanne
92
2
Izabela Zakrocka
Unknown
89
3
Carla Nester
University of Iowa Stead Family Children’s Hospital
82
4
Takashi Yokoo
Jikei University School of Medicine
81
5
Aili Cao
Shanghai Sixth People's Hospital
68
6
Gianna Mastroianni Kirsztajn
Universidade Federal de São Paulo
64
7
Dongmei Zhang
Central South University
63
8
Jens König
University Hospital Münster
61
9
Jie Xu
Ocean University of China
58
10
Melanie Deutsch
National and Kapodistrian University of Athens
56

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Fádi Fakhouri
University of Lausanne
99
2
Bingxue Qi
University of Dundee
53
3
Sebastian Mertowski
Medical University of Lublin
53
4
José C. De La Flor
Universidad de Alcalá
53
5
Fangcheng Zhang
Wuhan University
53
6
Marina Vivarelli
Bambino Gesù Children's Hospital
53
7
Shuangjin Yu
Jilin University
50
8
Dagmara Borzych–Dużałka
Gdańsk Medical University
50
9
Jean Patrick
James Paget University Hospitals NHS Foundation Trust
50
10
Tsigereda Weldemichael
University of Arkansas for Medical Sciences
50

Emerging Leaders Papers

1
O‐linked β‐N‐acetylglucosamine (O‐<scp>GlcNAc</scp>) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy
Diabetic Medicine|2024
19 cit.
2
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes
Clinical Kidney Journal|2024
2 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Chun Zhang
Union Hospital
99
2
Jochen Reiser
University of Miami
87
3
Peter F. Zipfel
Unknown
85
4
Fan Fan Hou
Nanfang Hospital
81
5
Kyung Lee
Icahn School of Medicine at Mount Sinai
77
6
Gerald B. Appel
Columbia University
77
7
Uzi Gafter
Rabin Medical Center
76
8
Surya V. Seshan
Cornell University
75
9
Franz Schaefer
Heidelberg University
74
10
Fernando C. Fervenza
Mayo Clinic
72

All-Time Leaders Papers

1
Non-Transgenic Mouse Models of Kidney Disease
˜The œNephron journals/Nephron journals|2016
1.9k cit.
2
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
Journal of Lipid Research|2013
627 cit.
3
Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults
Scientific Reports|2015
81 cit.
4
Circular RNA circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair
Nature Communications|2022
49 cit.
5
MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells
Journal of Cancer|2016
45 cit.
6
<scp>MDM</scp>2 is implicated in high‐glucose‐induced podocyte mitotic catastrophe <i>via</i> Notch1 signalling
Journal of Cellular and Molecular Medicine|2017
33 cit.
7
Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases
International Journal of Molecular Sciences|2022
28 cit.
8
Tussilagone Inhibits the Inflammatory Response and Improves Survival in CLP-Induced Septic Mice
International Journal of Molecular Sciences|2017
24 cit.
9
MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy
International Journal of Biological Sciences|2022
23 cit.
10
MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS
International Journal of Biological Sciences|2021
20 cit.

Indexing Renal Diseases and Glomerulopathies Reagents

Citation data for reagents in this field is currently compiling.